{
  "_meta": {
    "title": "Vaccine Injury Accountability — Master Timeline",
    "generated": "2026-04-18",
    "schema_version": "1.0.0",
    "scope": "Datestamped events from Sean Hartman's vaccination through Ontario Court of Appeal oral argument, plus surrounding regulatory and program-administration milestones. Every entry is primary-source cited."
  },

  "timeline": [
    {
      "date_iso": "2020-12-08",
      "event_title": "VISP eligibility start date",
      "description": "Canadians experiencing a serious and permanent injury after receiving a Health Canada authorized vaccine, administered in Canada, on or after 2020-12-08 are eligible to submit a claim to the federal Vaccine Injury Support Program.",
      "primary_source": "https://vaccineinjurysupport.ca/"
    },
    {
      "date_iso": "2021-06-10",
      "event_title": "VISP program announced",
      "description": "Public Health Agency of Canada announces the Vaccine Injury Support Program with initial projection of 40 claims per year.",
      "primary_source": "https://www.canada.ca/en/public-health/services/funding-opportunities/grant-contribution-funding-opportunities/call-applications-vaccine-injury-support-program.html"
    },
    {
      "date_iso": "2021-08-27",
      "event_title": "Sean Hartman vaccinated (Pfizer-BioNTech mRNA)",
      "description": "Sean Hartman, age 17, of Beeton, Ontario, receives the Pfizer-BioNTech COVID-19 mRNA vaccine during Ontario's adolescent rollout. Approximate date.",
      "primary_source": "https://childrenshealthdefense.ca/news/a-fathers-fight-for-justice-dan-hartmans-case-heads-to-the-ontario-court-of-appeal/"
    },
    {
      "date_iso": "2021-09-17",
      "event_title": "Sean Hartman dies suddenly — 21 days post-vaccination",
      "description": "Sean Hartman dies three weeks after vaccination. Tissue samples are later submitted to Dr. Ryan Cole (US pathologist) for independent examination; findings submitted with statement of claim support a vaccine-related cause of death.",
      "primary_source": "https://www.westernstandard.news/news/court-rejects-liability-claim-over-teens-vaccine-death/63460"
    },
    {
      "date_iso": "2022",
      "event_title": "PHAC confirms two COVID-19 vaccine safety signals",
      "description": "CAEFISS formally confirms: (1) thrombosis with thrombocytopenia syndrome (TTS) following AstraZeneca and Janssen; (2) myocarditis/pericarditis following Pfizer and Moderna mRNA products, with rates in under-40s higher than expected in that age group.",
      "primary_source": "https://www.canada.ca/en/public-health/services/immunization/canadian-adverse-events-following-immunization-surveillance-system-caefiss.html"
    },
    {
      "date_iso": "2022-12-21",
      "event_title": "$2.7M reported paid to 50 VISP claimants",
      "description": "CTV News reports $2.7M has been paid to 50 claimants of serious vaccine-related injury in Canada. First public indication of VISP approval rates.",
      "primary_source": "https://beta.ctvnews.ca/national/health/2022/12/21/1_6205187.amp.html"
    },
    {
      "date_iso": "2022",
      "event_title": "Ross Wightman approved by VISP — $270,000",
      "description": "British Columbia claimant Ross Wightman is approved by VISP for $270,000 but waits 20+ months for income replacement payment and cycles through 10 case managers. Describes the program as a 'dumpster fire'.",
      "primary_source": "https://globalnews.ca/news/11247648/covid-vaccine-injury-program-visp-oxaro-workplace-phac-2/"
    },
    {
      "date_iso": "2023-05",
      "event_title": "Dan Hartman files VISP appeal",
      "description": "Dan Hartman files an appeal within VISP after the initial claim is denied. As of April 2026 the appeal has been pending 32+ months without decision.",
      "primary_source": "https://globalnews.ca/news/11247648/covid-vaccine-injury-program-visp-oxaro-workplace-phac-2/"
    },
    {
      "date_iso": "2023-12-03",
      "event_title": "PHAC dashboard data cutoff (105,016,456 doses)",
      "description": "Public Health Agency of Canada vaccine safety dashboard data cutoff. Totals as reported: 105,016,456 doses administered; 58,712 AEFI reports; 11,702 serious AEFI reports (11.1 per 100,000 doses); 1,231 confirmed myocarditis/pericarditis cases (Brighton certainty 1-3); 89 confirmed TTS cases; 488 deaths reported after vaccination, 4 of which classified as 'consistent with causal association to immunization' by the Advisory Committee on Causality Assessment.",
      "primary_source": "https://health-infobase.canada.ca/covid-19/vaccine-safety/"
    },
    {
      "date_iso": "2024-07-05",
      "event_title": "Hartman files wrongful-death lawsuit against Pfizer and Health Canada",
      "description": "Dan Hartman sues Pfizer Canada and Health Canada for wrongful death of his son. Two alternative torts pleaded: negligence (Anns/Cooper) and misfeasance in public office. Plaintiff counsel: Umar Sheikh.",
      "primary_source": "https://www.westernstandard.news/news/court-rejects-liability-claim-over-teens-vaccine-death/63460"
    },
    {
      "date_iso": "2025-03",
      "event_title": "Ontario Superior Court dismisses Hartman claim",
      "description": "Justice Sandra Antoniani strikes the claim with no leave to amend. Holding: 'There is no private law duty of care to individual members of the public injured by government core policy decisions in the handling of health emergencies which impact the general population.'",
      "primary_source": "https://www.westernstandard.news/news/court-rejects-liability-claim-over-teens-vaccine-death/63460"
    },
    {
      "date_iso": "2025-06-01",
      "event_title": "VISP statistics — 3,317 claims / 234 approved (7.05%)",
      "description": "Government of Canada Question Period Note HC-2025-QP-0014 records: 3,317 total claims received; 2,699 deemed admissible for review; 352 rejected outright; 266 pending eligibility determination; 234 approved for payment; 420 Canadians launched appeals after denial.",
      "primary_source": "https://search.open.canada.ca/qpnotes/record/hc-sc,HC-2025-QP-0014"
    },
    {
      "date_iso": "2026-01-26",
      "event_title": "Ontario Court of Appeal hears Hartman v. Canada (AG)",
      "description": "ONCA item 24102. Three issues on appeal: (1) whether the trial judge erred applying Anns/Cooper; (2) whether she properly distinguished policy from operational acts; (3) whether she erred in striking the misfeasance-in-public-office claim. Decision reserved; expected within 6-18 months of oral argument.",
      "primary_source": "https://coadecisions.ontariocourts.ca/coa/coa/en/item/24102/index.do"
    },
    {
      "date_iso": "2026-04-01",
      "event_title": "VISP rebranded as VIAP — federal takeover",
      "description": "Canadian federal government takes direct control of the Vaccine Injury Support Program from contractor Oxaro Inc., rebranding as Vaccine Impact Assistance Program (VIAP) amid 'backlog and mismanagement concerns'. $50.6M of Oxaro contract value — $33.7M (67%) had gone to administration; $16.9M (33%) to injured Canadians.",
      "primary_source": "https://www.thecanadatimes.com/canada-takes-direct-control-of-vaccine-injury-compensation-program-amid-backlog-and-mismanagement-concerns/"
    }
  ],

  "pending_events": [
    {
      "event_title": "ONCA decision in Hartman v. Canada (AG) reserved",
      "expected_date_range": "2026-07 to 2027-07",
      "why_it_matters": "If ONCA upholds Justice Antoniani, tort law closes to every Canadian injured by government policy choices — VISP becomes the sole remedy, and VISP approves 7% of claims. If ONCA reverses, the Anns/Cooper test is formally recognised as applying to pandemic-era policy decisions, opening a class of new claims.",
      "tracked_at": "https://coadecisions.ontariocourts.ca/coa/coa/en/item/24102/index.do"
    },
    {
      "event_title": "VIAP first-year approval-rate disclosure",
      "expected_date_range": "2027-04",
      "why_it_matters": "The federal takeover from Oxaro (April 2026) will produce its own year-one statistics. If approval rates do not materially improve above Oxaro's 7.05%, the fault was not the contractor — it was the program design. If rates do improve, Oxaro's contract value should be clawed back."
    },
    {
      "event_title": "Possible Supreme Court of Canada leave application",
      "expected_date_range": "90 days after ONCA decision",
      "why_it_matters": "Whichever side loses at ONCA may apply to the Supreme Court of Canada for leave to appeal. SCC grants leave in roughly 10-12% of applications. If SCC takes the case, the Canadian duty-of-care doctrine for pandemic-era government policy is settled at the highest level."
    }
  ]
}